Skip to content

Drug interactions

Lasmiditan + Rifaximin

Severity: Moderate

Lasmiditan and Rifaximin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lasmiditan inhibits intestinal P-glycoprotein and may increase absorption of P-gp substrates. Rifaximin is a P-gp substrate with low normal absorption, so systemic exposure can rise, particularly with hepatic impairment. The clinical significance with usual doses is uncertain.

What this interaction means in plain words

Lasmiditan and Rifaximin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lasmiditan belongs to Central Nervous System; Rifaximin belongs to Anti Bacterial.

Evidence level: Low

Why it happens

Lasmiditan inhibits P-glycoprotein efflux, raising systemic exposure to rifaximin.

What to do

Monitor for rifaximin adverse effects, particularly in patients with severe hepatic impairment. Consider avoiding lasmiditan for a patient on long-term rifaximin with advanced liver disease.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lasmiditan and Rifaximin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lasmiditan with Rifaximin?

MediHelp rates the interaction as moderate. Lasmiditan and Rifaximin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lasmiditan inhibits intestinal P-glycoprotein and may increase absorption of P-gp substrates. Rifaximin is a P-gp substrate with low normal absorption, so systemic exposure can rise, particularly with hepatic impairment. The clinical significance with usual doses is uncertain.

How serious is the interaction between Lasmiditan and Rifaximin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for rifaximin adverse effects, particularly in patients with severe hepatic impairment. Consider avoiding lasmiditan for a patient on long-term rifaximin with advanced liver disease.

What other medicines interact with Rifaximin?

MediHelp also lists interactions of Rifaximin with, for example, Cholera vaccine, Microbiota, Amiodarone. The full list is on the Rifaximin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in